In the first episode of our second season, hosts David Anderson and Gina Vitale travel back in time to relive three historical moments that led to blockbuster drugs like Ozempic and Wegovy. They also talk with C&EN reporter Aayushi Pratap about how future GLP-1 drugs may expand on the current slate of options. C&EN's latest podcast, Inflection Point, leans on our 100-year archive to trace headline topics in science today back to their disparate and surprising roots. In each episode, we explore three lesser-known moments in science history that ultimately led us to current-day breakthroughs. With help from expert C&EN reporters, this new show examines how discoveries from our past have shaped our present and will change our future. Subscribe to Inflection Point now on Apple Podcasts, Spotify, or wherever you get your podcasts.
AI Summary coming soon
Sign up to get notified when the full AI-powered summary is ready.
Free forever for up to 3 podcasts. No credit card required.
Listen to This Episode
More from Inflection Point
Bonus: Celebrating 1 year of Inflection Point!
The electric innovations that brought lithium-ion batteries online
The ancient, 'juicy' origins of antibiotic resistance
The era-spanning epiphanies that enabled gene editing
Get summaries like this every morning.
Free AI-powered recaps of Inflection Point and your other favorite podcasts, delivered to your inbox.
Free forever for up to 3 podcasts. No credit card required.